Topical glucocorticoids and anti-infectives: a rational combination?
Zienicke
H
H
Dermatologische Klinik und Poliklinik, Ludwig-Maximilians-Universität München, BRD.
D000279:Administration, Cutaneous; D000328:Adult; D000890:Anti-Infective Agents / Q000008:administration & dosage*; D003876:Dermatitis, Atopic / Q000150:complications / Q000188:drug therapy*; D004311:Double-Blind Method; D004338:Drug Combinations; D005260:Female; D006801:Humans; D008297:Male; D011239:Prednisolone / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000627:therapeutic use; D000644:Quaternary Ammonium Compounds / Q000008:administration & dosage* / Q000627:therapeutic use; D013207:Staphylococcal Skin Infections / Q000150:complications / Q000188:drug therapy*; D016896:Treatment Outcome
D000890:Anti-Infective Agents; D004338:Drug Combinations; D000644:Quaternary Ammonium Compounds; D011239:Prednisolone; C035287:prednicarbate; C027118:didecyldimethylammonium